Arcellx (ACLX) Operating Leases (2022 - 2025)

Arcellx's (ACLX) quarterly Operating Leases came in at $44.3 million in Q4 2025, down 4.73% year-on-year from $46.5 million in Q4 2024, and little changed quarter-over-quarter from $44.3 million in Q3 2025.

Arcellx (ACLX) Operating Leases (2022 - 2025) Analysis & Trends

Arcellx's Operating Leases history runs 4 years deep, the most recent figure standing at $44.3 million for Q4 2025.

  • On a quarterly basis, Operating Leases fell 4.73% year-over-year to $44.3 million in Q4 2025; TTM through Dec 2025 was $44.3 million, a 4.73% decrease from a year earlier, with the FY2025 full-year figure at $44.3 million, down 4.73% from the prior year.
  • Operating Leases steadied at $44.3 million in Q4 2025 per ACLX's latest filing, from $44.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $50.8 million in Q4 2023 and bottomed at $4.5 million in Q1 2022.
  • The 4-year median for Operating Leases is $44.7 million (2025), against an average of $39.5 million.
  • Across the five-year window, Operating Leases surged 610.98% in 2023 and dropped 8.46% in 2024, its largest moves.
  • Year by year, Operating Leases stood at $31.3 million in 2022, then soared by 62.44% to $50.8 million in 2023, then retreated by 8.46% to $46.5 million in 2024, then dropped by 4.73% to $44.3 million in 2025.
  • Per Business Quant, the three latest ACLX Operating Leases figures stand at $44.3 million (Q4 2025), $44.3 million (Q3 2025), and $45.1 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Arcellx 6.48 Bn 6.48 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 44.34 Mn
Sep 30, 2025 44.32 Mn
Jun 30, 2025 45.10 Mn
Mar 31, 2025 45.83 Mn
Dec 31, 2024 46.54 Mn
Sep 30, 2024 47.21 Mn
Jun 30, 2024 47.87 Mn
Mar 31, 2024 47.69 Mn
Dec 31, 2023 50.84 Mn
Sep 30, 2023 48.10 Mn
Jun 30, 2023 40.64 Mn
Mar 31, 2023 31.99 Mn
Dec 31, 2022 31.30 Mn
Sep 30, 2022 29.21 Mn
Jun 30, 2022 27.20 Mn
Mar 31, 2022 4.50 Mn